Advertisement

Topics

Clinical Trials About "Utility Horizontal Sections Scalp Biopsies Differentiating between Androgenetic" RSS

07:42 EDT 25th March 2019 | BioPortfolio

We list hundreds of Clinical Trials about "Utility Horizontal Sections Scalp Biopsies Differentiating between Androgenetic" on BioPortfolio. We draw our references from global clinical trials data listed on ClinicalTrials.gov and refresh our database daily.

More Information about "Utility Horizontal Sections Scalp Biopsies Differentiating between Androgenetic" on BioPortfolio

We have published hundreds of Utility Horizontal Sections Scalp Biopsies Differentiating between Androgenetic news stories on BioPortfolio along with dozens of Utility Horizontal Sections Scalp Biopsies Differentiating between Androgenetic Clinical Trials and PubMed Articles about Utility Horizontal Sections Scalp Biopsies Differentiating between Androgenetic for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Utility Horizontal Sections Scalp Biopsies Differentiating between Androgenetic Companies in our database. You can also find out about relevant Utility Horizontal Sections Scalp Biopsies Differentiating between Androgenetic Drugs and Medications on this site too.

Showing "Utility Horizontal Sections Scalp Biopsies Differentiating between Androgenetic" Clinical Trials 1–25 of 2,500+

Extremely Relevant

A Study of SM04554 Applied Topically to the Scalp of Male Subjects With Androgenetic Alopecia Analyzed by Biopsy of the Scalp Prior To and Post Dosing

This study will assess the safety, tolerability, and efficacy of SM04554 at concentrations of 0.15% and 0.25%. Improved knowledge of the changes in hair counts and immunohistochemical analysis associated with androgenetic alopecia (AGA) before and after treatment with SM04554 and compared to placebo may lead to a greater understanding of the underlying mechanisms of action of SM04554.


The Effect of Microneedling With Low Energy Laser in Androgenic Alopecia Patients.

Androgenetic alopecia is the most common type of hair loss in men, and affects approximately 50 percent of Caucasian men by age 50. The condition is characterized by the progressive loss of terminal hairs on the scalp in a characteristic distribution. The anterior scalp, mid scalp, temporal scalp, and vertex of the scalp are typical sites of involvement. "Male balding" and "male pattern hair loss" are additional terms used to refer to this condition. The aim of this study is t...

Relevant

Local Pharmacokinetics and Tolerability of Bimatoprost Applied to the Scalp of Male Patients With Androgenetic Alopecia

This study will evaluate the skin pharmacokinetics and tolerability of bimatoprost Formulation A and Formulation B following 14 days of once daily topical administration in male participants with androgenetic alopecia (AGA).


A Study Evaluating the Efficacy and Safety of SM04554 Topical Solution in Male Subjects With Androgenetic Alopecia

This multi-center, randomized, double-blind, placebo-controlled study, conducted in Turkey, will assess the efficacy and safety of topical SM04554 solution (0.15% and 0.25%) applied daily to the scalp of male androgenetic alopecia (AGA) subjects.

A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA)

The purpose of this study is to characterize the safety, tolerability, and efficacy of topical SM04554 solution (0.15% and 0.25%) applied to the scalp of male subjects with Androgenetic Alopecia (AGA).

Dose-Ranging Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss

The purpose of this study is to evaluate the safety and efficacy of three doses of topical NEOSH101 applied once-daily (qd) for 16 weeks in men with thinning hair in the top and center of the scalp (Norwood/Hamilton grades III-IV androgenetic alopecia). Four equally sized treatment groups (35 men each) will receive either NEOSH101 0.5%, NEOSH101 1.0%, NEOSH101 2.0% or placebo. A 12-week observation period will follow the treatment period.

Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss

The purpose of this study is to measure the hair growth response to topical NEOSH101 when applied twice daily to the balding scalp for 16 weeks. One hundred eighty men with Norwood/Hamilton grades III-IV with thinning in the top and center of the scalp will participate. Three equally sized treatment groups (60 men each) will receive either topical NEOSH101 2.0%, minoxidil 5%, or placebo.

Treatment of Androgenetic Alopecia in Males

The purpose of this study is to evaluate the efficacy of the HairMax LaserComb 2009 7 Beam model in promoting hair growth in men diagnosed with androgenetic alopecia when treatment is applied as directed.

Treatment of Androgenetic Alopecia in Females, 9 Beam

The purpose of this study is to evaluate the efficacy of the HairMax LaserComb 2009 9 beam model in promoting hair growth in females diagnosed with androgenetic alopecia when treatment is applied as directed.

Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia

The purpose of this study is to confirm the clinical efficacy and the safety of P-3074 in patients with androgenetic alopecia.

Adipose Derived Stem Cells Versus Platelet Rich Plasma on Follicular Unit Extraction

Androgenetic alopecia is the most common type of alopecia in both men and women. About 80 % of Caucasian men and 40-50 % of Caucasian women are affected by androgenetic alopecia. The psychological impact of hair loss due to Androgenetic alopecia can be profound.

Hairmax Lasercomb For The Treatment Of Androgenetic Alopecia In Females

HairMax 12 2009-F-02 is a double blind study to evaluate the treatment of androgenetic alopecia.

A Phase 2 Study to Evaluate the Safety and Efficacy of CB-03-01 Solution, a Comparator Solution and Vehicle Solution in Males With Androgenetic Alopecia

In this proof-of-concept study, the safety and efficacy of a solution formulation will be investigated in male subjects with androgenetic alopecia (AGA) after twice daily application for up to 26 weeks.

Trichoscopy in Diagnosis of Immunobollous Diseases

Autoimmune bullous diseases are a variety of skin diseases that are characterized by the presence of bullae or blisters. Most of these diseases are associated with substantial morbidity and mortality. They are classified according to the site of blister formation into intraepidermal as pemphigus valgaris and foliaceus, and subepidermal as bullous pemphigoid and dermatitis herpetiformis. These lesions commonly affect the scalp and manifest as blisters, erosions and crustations. ...

A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical Solution

Open label study to assess safety, tolerability, and efficacy of ATI-50002 in male and female subjects with androgenetic alopecia.

Efficacy and Safety Study to Compare Two Minoxidil Formulations on Women With Androgenetic Alopecia

The purpose of this study is to determine in women the risk/benefit profile and non-inferiority of a topical 5% Minoxidil foam formulation applied once daily for the treatment of androgenetic alopecia in comparison to 2% MTS used twice daily, using objective and subjective efficacy measures and safety assessments for a study period of 24 weeks.

A Study To Assess The Efficacy And Safety Of Dutasteride 0.5mg Once Daily For 6 Months In The Treatment Of Male Subjects With Androgenetic Alopecia

The aim of this Phase III study is to compare the efficacy, safety and tolerability of dutasteride (0.5mg) with placebo for 6 months, in Korean male subjects with androgenetic alopecia in the vertex region, types IIIv, IV and V according to the modified Norwood-Hamilton Classification.

Safety and Efficacy of a Topical Scalp Treatment for Dry Scalp Conditions in Children and Adult

The purpose of this study is to determine if YoBee, a topical treatment for dry scalp conditions, is safe and effective in clinically improving dry scalp conditions. The investigators will additionally examine individuals experience in using Yobee as well as any changes in the scalp microbiome before and after use studying YoBee , the investigators hope to offer children and adults a new, natural way to improve dry scalp conditions.

Adipose Tissue Derived Stem Cell Based Hair Restoration Therapy for Androgenetic Alopecia

Androgenetic alopecia (AGA) is a common form of hair loss in both men and women, characterized by progressive patterned loss of hair from the scalp. The current study has been designed for restoration of hair in AGA by implanting a combination of autologous mesenchymal stem cells (derived from the adipose tissue) and human platelet rich plasma.

The Effect of Platelet-rich Plasma in Subjects With Androgenetic Alopecia

The purpose of this study is to evaluate the effect of autologous platelet-rich plasma (PRP) in the treatment of androgenetic alopecia. This is a randomized clinical trial to evaluate the effect of autologous platelet rich plasma in subjects with moderate androgenetic alopecia. Approximately 30 subjects will be randomized into the study. The study is designed as an 18-month study consisting of 2 phases. This study was a pilot study designed to determine feasibility of this pro...

Scalp Block in Elective Craniotomy for Tumor Dissection Trial

This study was designed to evaluate the effect of scalp block combined with general anesthesia on the intraoperative consumption of fentanyl and time of extubation of patients undergoing elective craniotomy. Scalp block will be applied to three groups with differences of the administered solution to the scalp and one group will be placebo group.

Treatment of Androgenetic Alopecia in Females, 12 Beam

The purpose of this study is to evaluate the efficacy of the HairMax LaserComb 2009 12 beam model for androgenetic alopecia in females when treatment is applied as directed.

Treatment of Androgenetic Alopecia in Males With Theradome™ LH80 PRO

This is a prospective, randomized double-blind, multi-center study to evaluate the efficacy of low level laser therapy over-the-counter at home device Theradome LH80 PRO, compared to SHAM for promoting hair growth in males diagnosed with androgenetic alopecia, and a usability study to assess subject ability to self-assess hair loss and understanding use of the device.

Evaluation of Scalp and Hair Shaft With Biologic Markers in African American and Caucasian Hair

The purpose of this research study is to better understand African American hair and scalp, its biologic appearance and how this relates to African Americans' perceptions of their hair and scalp health. Since most hair studies have looked at Caucasian hair and scalp, we will use a population of Caucasian subjects for comparison in evaluating various hair and scalp parameters.

To Evaluate the Therapeutic Equivalence and Safety in Treatment of Scalp Psoriasis

To demonstrate the superiority of the efficacy of the test and reference products over that of the placebo control in the treatment of scalp psoriasis.


More From BioPortfolio on "Utility Horizontal Sections Scalp Biopsies Differentiating between Androgenetic"

Advertisement
Quick Search
Advertisement
Advertisement